Crucial Elements in Jurisdiction COVID-19 Vaccine Planning
There are a number of different elements for any jurisdiction to consider when planning for a COVID-19 vaccine administration program.
Read more >BY Marcey Propp ON CDC | COVID-19 | Immunization Information System (IIS)
There are a number of different elements for any jurisdiction to consider when planning for a COVID-19 vaccine administration program.
Read more >BY Noam Arzt ON CDC | COVID-19 | Emergency Preparedness and Biodefense | Immunization Calculation Engine (ICE) | Open Source | Planning
We discuss the data management realities to the large-scale administration of one or more new COVID-19 vaccines.
Read more >BY Noam Arzt ON CDC | COVID-19 | CSTE | Electronic Case Reporting (eCR) | Emergency Preparedness and Biodefense | FHIR | Open Source | RCKMS
As people begin to spend more time together again, it is critically important that public health agencies do everything they can to help prevent further spread of the infection and continue to monitor the level of infection within the population. A national project has been underway to implement electronic case reporting (eCR).
Read more >BY Noam Arzt ON CDC | Clinical Decision Support (CDS) | COVID-19 | CSTE | EHR/PHR | Electronic Case Reporting (eCR) | Emergency Preparedness and Biodefense | FHIR | HIE & Interoperability | HL7 | Open Source | RCKMS
On June 10, 2020 the US Senate released a white paper titled “Preparing for the Next Pandemic” under the signature of Senator Lamar Alexander of Tennessee. The white paper has five recommendations to address future pandemics based on lessons learned from COVID-19 and the past 20 years of pandemic planning.
Read more >BY Noam Arzt ON Clinical Decision Support (CDS) | COVID-19 | FHIR | Immunization Calculation Engine (ICE) | Open Source
Like many things in the age of COVID-19, the vaccine development landscape is unlike anything we have seen in our lifetimes. There are over 100 SARS-CoV-2 vaccines currently in development, many of which are utilizing new technologies not used in any currently licensed vaccine. The potential impact on immunization schedules (clinical guidelines for clinicians) and immunization clinical decision support is significant.
Read more >